Inhibitors of PI3Kβ as Potential Treatment for Cancer

被引：1
|
作者：
Abdel-Magid, Ahmed F. [1 ]
机构：
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 09期
关键词：
D O I：
10.1021/ml400274v
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：815 / 816
页数：2
相关论文
共 50 条
  • [31] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [32] The present and future of PI3K inhibitors for cancer therapy
    Pau Castel
    Eneda Toska
    Jeffrey A. Engelman
    Maurizio Scaltriti
    Nature Cancer, 2021, 2 : 587 - 597
  • [33] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [34] Phytochemicals and PI3K Inhibitors in Cancer-An Insight
    Suvarna, Vasanti
    Murahari, Manikanta
    Khan, Tabassum
    Chaubey, Pramila
    Sangave, Preeti
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [35] The present and future of PI3K inhibitors for cancer therapy
    Castel, Pau
    Toska, Eneda
    Engelman, Jeffrey A.
    Scaltriti, Maurizio
    NATURE CANCER, 2021, 2 (06) : 587 - 597
  • [36] Imidazopyridazine Inhibitors of PI3Kβ
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (12): : 1012 - 1013
  • [37] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [38] Development of PI3K inhibitors in breast cancer.
    Ma, Cynthia X.
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 22 - 23
  • [39] Efficacy of PI3K inhibitors in advanced breast cancer
    Verret, B.
    Cortes, J.
    Bachelot, T.
    Andre, F.
    Arnedos, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 12 - 20
  • [40] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
12345